纵横研报
Ticker Detail

600222.SHG

¥7.89+0.90% 太龙药业 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
Henan Taloph Pharmaceutical Stock Co Ltd
医疗健康 · 专科与仿制药

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the manufacture and sale of pharmaceutical preparations and Chinese herbal medicine slices in China. The company offers Shuanghuanglian oral liquid series, Shuangjinlian mixture, children's heat-clearing and cough-relieving oral liquid series, pediatric antipyretic oral liquid, Jiaweishanxiang Zhengqi compound preparation, honeysuckle dew, danshen oral liquid, Shengmai Yin, pediatric compound chicken gizzard chewable tablets, Chewable tablets, huperzine A tablets, Wuzi Yanzong oral liquid, compound motherwort oral liquid, etc. It is also involved in pharmaceutical research and development, and medicine and medicinal materials distribution. The company's medicine preparations are used in the treatment of respiratory system, cardiovascular and cerebrovascular, digestive system, nervous system, menstrual system, reproductive system, and gynecological diseases. Henan Taloph Pharmaceutical Stock Co.,Ltd was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. The company was founded in 1998 and is based in Zhengzhou, China.

MARKET 市值 4.14B CNY PE 67.4x Fwd 56.2x 52W ¥5.99 – ¥9.44 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 8.3% ROE 4.0% 营业利润率 5.1% 净利润率 3.4%
ANALYST 股息率 0.19%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制